Standard
Botulinum toxin for prevention of post-operative atrial fibrillation. / Saljic, Arnela; Hansen, Malthe Emil Høtbjerg; Dobrev, Dobromir.
In:
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 396, No. 3, 2023, p. 385-388.
Research output: Contribution to journal › Editorial › Research › peer-review
Harvard
Saljic, A, Hansen, MEH & Dobrev, D 2023, '
Botulinum toxin for prevention of post-operative atrial fibrillation',
Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 396, no. 3, pp. 385-388.
https://doi.org/10.1007/s00210-023-02402-y
APA
Saljic, A., Hansen, M. E. H., & Dobrev, D. (2023).
Botulinum toxin for prevention of post-operative atrial fibrillation.
Naunyn-Schmiedeberg's Archives of Pharmacology,
396(3), 385-388.
https://doi.org/10.1007/s00210-023-02402-y
Vancouver
Saljic A, Hansen MEH, Dobrev D.
Botulinum toxin for prevention of post-operative atrial fibrillation.
Naunyn-Schmiedeberg's Archives of Pharmacology. 2023;396(3):385-388.
https://doi.org/10.1007/s00210-023-02402-y
Author
Saljic, Arnela ; Hansen, Malthe Emil Høtbjerg ; Dobrev, Dobromir. / Botulinum toxin for prevention of post-operative atrial fibrillation. In: Naunyn-Schmiedeberg's Archives of Pharmacology. 2023 ; Vol. 396, No. 3. pp. 385-388.
Bibtex
@article{d8a2a22875dc49bfb0a2f15f4c99c9a7,
title = "Botulinum toxin for prevention of post-operative atrial fibrillation",
author = "Arnela Saljic and Hansen, {Malthe Emil H{\o}tbjerg} and Dobromir Dobrev",
note = "Funding Information: The authors{\textquoteright} work is supported by the National Institutes of Health (R01-HL131517, R01-HL136389, R01-HL089598, and R01-HL163277 to DD), the European Union (large-scale integrative project MAESTRIA, No. 965286 to DD), the Independent Research Fund Denmark (102900011B to AS) and the Novo Nordisk Foundation (NNF21OC0066480). ",
year = "2023",
doi = "10.1007/s00210-023-02402-y",
language = "English",
volume = "396",
pages = "385--388",
journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",
issn = "0028-1298",
publisher = "Springer",
number = "3",
}
RIS
TY - JOUR
T1 - Botulinum toxin for prevention of post-operative atrial fibrillation
AU - Saljic, Arnela
AU - Hansen, Malthe Emil Høtbjerg
AU - Dobrev, Dobromir
N1 - Funding Information:
The authors’ work is supported by the National Institutes of Health (R01-HL131517, R01-HL136389, R01-HL089598, and R01-HL163277 to DD), the European Union (large-scale integrative project MAESTRIA, No. 965286 to DD), the Independent Research Fund Denmark (102900011B to AS) and the Novo Nordisk Foundation (NNF21OC0066480).
PY - 2023
Y1 - 2023
UR - http://www.scopus.com/inward/record.url?scp=85146983662&partnerID=8YFLogxK
U2 - 10.1007/s00210-023-02402-y
DO - 10.1007/s00210-023-02402-y
M3 - Editorial
C2 - 36715734
AN - SCOPUS:85146983662
VL - 396
SP - 385
EP - 388
JO - Naunyn-Schmiedeberg's Archives of Pharmacology
JF - Naunyn-Schmiedeberg's Archives of Pharmacology
SN - 0028-1298
IS - 3
ER -